6.93
0.43%
0.03
After Hours:
6.93
Nu Skin Enterprises Inc stock is traded at $6.93, with a volume of 326.64K.
It is up +0.43% in the last 24 hours and up +3.74% over the past month.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
See More
Previous Close:
$6.90
Open:
$6.93
24h Volume:
326.64K
Relative Volume:
0.44
Market Cap:
$344.50M
Revenue:
$1.97B
Net Income/Loss:
$8.60M
P/E Ratio:
38.50
EPS:
0.18
Net Cash Flow:
$60.15M
1W Performance:
-2.94%
1M Performance:
+3.74%
6M Performance:
-38.01%
1Y Performance:
-62.92%
Nu Skin Enterprises Inc Stock (NUS) Company Profile
Name
Nu Skin Enterprises Inc
Sector
Industry
Phone
801-345-1000
Address
75 WEST CENTER ST, PROVO, UT
Compare NUS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
NUS
Nu Skin Enterprises Inc
|
6.93 | 344.50M | 1.97B | 8.60M | 60.15M | 0.18 |
PG
Procter Gamble Co
|
167.41 | 392.55B | 84.35B | 15.48B | 15.47B | 6.28 |
UL
Unilever Plc Adr
|
58.30 | 144.19B | 64.93B | 7.15B | 0 | 2.832 |
CL
Colgate Palmolive Co
|
90.89 | 74.26B | 20.11B | 2.87B | 3.40B | 3.49 |
KMB
Kimberly Clark Corp
|
130.85 | 43.42B | 20.06B | 2.55B | 2.51B | 7.55 |
KVUE
Kenvue Inc
|
21.72 | 41.64B | 15.46B | 1.06B | 1.40B | 0.55 |
Nu Skin Enterprises Inc Stock (NUS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-31-23 | Downgrade | Jefferies | Buy → Hold |
Feb-12-21 | Downgrade | DA Davidson | Buy → Neutral |
Oct-02-20 | Upgrade | BofA Securities | Underperform → Neutral |
Jul-02-20 | Upgrade | DA Davidson | Neutral → Buy |
Jul-02-20 | Upgrade | Jefferies | Hold → Buy |
Mar-09-20 | Downgrade | Deutsche Bank | Buy → Hold |
Dec-05-19 | Resumed | Citigroup | Neutral |
Nov-06-19 | Downgrade | Citigroup | Buy → Neutral |
Oct-30-19 | Upgrade | Stifel | Sell → Hold |
Jul-17-19 | Downgrade | DA Davidson | Buy → Neutral |
Jul-17-19 | Downgrade | Jefferies | Buy → Hold |
Jun-19-19 | Reiterated | BofA/Merrill | Underperform |
May-01-19 | Reiterated | BofA/Merrill | Underperform |
May-01-19 | Upgrade | Deutsche Bank | Hold → Buy |
Apr-12-19 | Reiterated | BofA/Merrill | Underperform |
Mar-25-19 | Downgrade | Stifel | Hold → Sell |
Dec-06-18 | Reiterated | BofA/Merrill | Underperform |
Oct-10-18 | Initiated | DA Davidson | Buy |
Aug-03-18 | Upgrade | Stifel | Sell → Hold |
Jun-14-18 | Initiated | Jefferies | Buy |
Feb-16-18 | Reiterated | Stifel | Sell |
Jan-23-18 | Reiterated | Citigroup | Buy |
View All
Nu Skin Enterprises Inc Stock (NUS) Latest News
Direct selling in Utah 2025: Top MLM companies in Utah redefining direct selling trends - Epixel MLM Software
Nu Skin Enterprises (NUS) Stock Price, News & Analysis - MarketBeat
JPMorgan Chase & Co. Acquires 147,784 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) - MarketBeat
NUS Q4 Preliminary Revenues Reach Top End of Outlook, Stock Gains 9.8% - MSN
What Does Nu Skin's Mavely Sale Mean for Its Long-Term Strategy? - MSN
Nu Skin Enterprises rises 4.3%, sells Mavely platform for $250 million - MSN
Nu Skin Enterprises, Inc. (NYSE:NUS) Sees Large Decline in Short Interest - MarketBeat
Barclays PLC Raises Stake in Nu Skin Enterprises, Inc. (NYSE:NUS) - MarketBeat
Nu Skin hits Q4 revenue target, to present at ICR Conference - Investing.com Canada
Nu Skin (NUS) Surges on Strong Guidance and Strategic Updates - GuruFocus.com
Nu Skin rallies after favorable guidance update - MSN
Nu Skin hits Q4 revenue target, to present at ICR Conference By Investing.com - Investing.com South Africa
Nu Skin Enterprises (NYSE:NUS) Releases Q4 2024 Earnings Guidance - MarketBeat
Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance - Business Wire
Institutional owners may take dramatic actions as Nu Skin Enterprises, Inc.'s (NYSE:NUS) recent 17% drop adds to one-year losses - Simply Wall St
Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth (NYSE:NUS) - Seeking Alpha
Nu Skin Enterprises jumps on a deal to sell its Mavely marketing tech platform - MSN
Nu Skin Enterprises announces strategic transaction of Mavely for $250M - Utah Business
Nu Skin Enterprises (NUS) Stock Dips Amid Market Volatility - GuruFocus.com
Nu Skin Sells Its Mavely Amidst Industry Competition - GuruFocus.com
Later Acquires Mavely for $250 Million, Unlocking New Opportunities for Marketers and Creators to Maximize their Return on Social - Marketscreener.com
Nu Skin Sells Mavely Platform to Later for $250M - Yahoo Finance
Nu Skin unit sells Mavely platform to Later for $250 million - Investing.com Nigeria
Nu Skin’s Rhyz Sells Mavely in $250 Million Strategic Transaction - Direct Selling News
Nu Skin’s Rhyz completes sale of Mavely for $250M - MSN
Nu Skin (NUS) Soars on Sale of Mavely Platform - GuruFocus.com
Nu Skin (NUS) Up 17% at Pre-Market Trade After Raising $250M Fresh Funds - MSN
Nu Skin (NUS) Shares Skyrocket, What You Need To Know - Yahoo Finance
Nu Skin Enterprises jumps on a deal to sell its Mavely marketing technology platfo - Investing.com India
Nu Skin Enterprises’ Rhyz Sells Mavely Affiliate to Portfolio Company Later in $250 Million Cash Deal - Happi
Why Is Nu Skin Enterprises Stock Jumping Today? - Benzinga
Nu Skin Enterprises Inc Stock (NUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):